TrialTrials2019

Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study.

Derick Wade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.